Literature DB >> 33465118

The role of posttranslational modifications in generating neo-epitopes that bind to rheumatoid arthritis-associated HLA-DR alleles and promote autoimmune T cell responses.

Stephane Becart1, Karen B Whittington2, Amanda Prislovsky2, Navin L Rao3, Edward F Rosloniec2,4,5.   

Abstract

While antibodies to citrullinated proteins have become a diagnostic hallmark in rheumatoid arthritis (RA), we still do not understand how the autoimmune T cell response is influenced by these citrullinated proteins. To investigate the role of citrullinated antigens in HLA-DR1- and DR4-restricted T cell responses, we utilized mouse models that express these MHC-II alleles to determine the relationship between citrullinated peptide affinity for these DR molecules and the ability of these peptides to induce a T cell response. Using a set of peptides from proteins thought to be targeted by the autoimmune T cell responses in RA, aggrecan, vimentin, fibrinogen, and type II collagen, we found that while citrullination can enhance the binding affinity for these DR alleles, it does not always do so, even when in the critical P4 position. Moreover, if peptide citrullination does enhance HLA-DR binding affinity, it does not necessarily predict the generation of a T cell response. Conversely, citrullinated peptides can stimulate T cells without changing the peptide binding affinity for HLA-DR1 or DR4. Furthermore, citrullination of an autoantigen, type II collagen, which enhances binding affinity to HLA-DR1 did not enhance the severity of autoimmune arthritis in HLA-DR1 transgenic mice. Additional analysis of clonal T cell populations stimulated by these peptides indicated cross recognition of citrullinated and wild type peptides can occur in some instances, while in others cases the citrullination generates a novel T cell epitope. Finally, cytokine profiles of the wild type and citrullinated peptide stimulated T cells unveiled a significant disconnect between proliferation and cytokine production. Altogether, these data demonstrate the lack of support for a simplified model with universal correlation between affinity for HLA-DR alleles, immunogenicity and arthritogenicity of citrullinated peptides. Additionally they highlight the complexity of both T cell receptor recognition of citrulline as well as its potential conformational effects on the peptide:HLA-DR complex as recognized by a self-reactive cell receptor.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33465118      PMCID: PMC7815092          DOI: 10.1371/journal.pone.0245541

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  60 in total

1.  Generation of neoantigenic epitopes after posttranslational modification of type II collagen by factors present within the inflamed joint.

Authors:  Ahuva Nissim; Paul G Winyard; Valerie Corrigall; Rewas Fatah; David Perrett; Gabriel Panayi; Yuti Chernajovsky
Journal:  Arthritis Rheum       Date:  2005-12

2.  Crystallization of HLA-DR antigens.

Authors:  J C Gorga; J H Brown; T Jardetzky; D C Wiley; J L Strominger
Journal:  Res Immunol       Date:  1991 Jun-Aug

Review 3.  Immunity to citrullinated proteins in rheumatoid arthritis.

Authors:  Lars Klareskog; Johan Rönnelid; Karin Lundberg; Leonid Padyukov; Lars Alfredsson
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

4.  Collagen-induced arthritis.

Authors:  Edward F Rosloniec; Michael Cremer; Andrew H Kang; Linda K Myers; David D Brand
Journal:  Curr Protoc Immunol       Date:  2010-04

5.  The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis.

Authors:  Annette H M van der Helm-van Mil; Kirsten N Verpoort; Ferdinand C Breedveld; Tom W J Huizinga; René E M Toes; René R P de Vries
Journal:  Arthritis Rheum       Date:  2006-04

6.  Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen.

Authors:  E F Rosloniec; D D Brand; L K Myers; Y Esaki; K B Whittington; D M Zaller; A Woods; J M Stuart; A H Kang
Journal:  J Immunol       Date:  1998-03-15       Impact factor: 5.422

Review 7.  Rheumatoid arthritis in American Indians and Alaska Natives: a review of the literature.

Authors:  Elizabeth D Ferucci; David W Templin; Anne P Lanier
Journal:  Semin Arthritis Rheum       Date:  2005-02       Impact factor: 5.532

8.  The shared epitope hypothesis in rheumatoid arthritis: evaluation of alternative classification criteria in a large UK Caucasian cohort.

Authors:  Ann W Morgan; Lubna Haroon-Rashid; Stephen G Martin; Hock-Chye Gooi; Jane Worthington; Wendy Thomson; Jennifer H Barrett; Paul Emery
Journal:  Arthritis Rheum       Date:  2008-05

9.  Citrulline-specific Th1 cells are increased in rheumatoid arthritis and their frequency is influenced by disease duration and therapy.

Authors:  Eddie A James; Mary Rieck; Jennifer Pieper; John A Gebe; Betty B Yue; Megan Tatum; Melissa Peda; Charlotta Sandin; Lars Klareskog; Vivianne Malmström; Jane H Buckner
Journal:  Arthritis Rheumatol       Date:  2014-07       Impact factor: 10.995

10.  An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen.

Authors:  E F Rosloniec; D D Brand; L K Myers; K B Whittington; M Gumanovskaya; D M Zaller; A Woods; D M Altmann; J M Stuart; A H Kang
Journal:  J Exp Med       Date:  1997-03-17       Impact factor: 14.307

View more
  7 in total

Review 1.  Emerging proteoglycans and proteoglycan-targeted therapies in rheumatoid arthritis.

Authors:  Brianna Hurysz; Nunzio Bottini
Journal:  Am J Physiol Cell Physiol       Date:  2022-04-27       Impact factor: 5.282

Review 2.  The virtues and vices of protein citrullination.

Authors:  Maria A Christophorou
Journal:  R Soc Open Sci       Date:  2022-06-08       Impact factor: 3.653

3.  Increased susceptibility to organic dust exposure-induced inflammatory lung disease with enhanced rheumatoid arthritis-associated autoantigen expression in HLA-DR4 transgenic mice.

Authors:  Jill A Poole; Ted R Mikuls; Geoffrey M Thiele; Rohit Gaurav; Amy J Nelson; Michael J Duryee; Ananya Mitra; Carlos Hunter; Todd A Wyatt; Bryant R England; Dana P Ascherman
Journal:  Respir Res       Date:  2022-06-18

Review 4.  Emerging Concepts in Immune Thrombotic Thrombocytopenic Purpura.

Authors:  Aicha Laghmouchi; Nuno A G Graça; Jan Voorberg
Journal:  Front Immunol       Date:  2021-11-11       Impact factor: 7.561

Review 5.  HLA-G and the MHC Cusp Theory.

Authors:  Bruna Miglioranza Scavuzzi; Vincent van Drongelen; Joseph Holoshitz
Journal:  Front Immunol       Date:  2022-02-25       Impact factor: 7.561

6.  Vaccine Can Induce CD4-Mediated Responses to Homocitrullinated Peptides via Multiple HLA-Types and Confer Anti-Tumor Immunity.

Authors:  Katherine Cook; Wei Xue; Suha Atabani; Peter Symonds; Abdullah Al Omari; Ian Daniels; Sabaria Shah; Ruhul Hasan Choudhury; Daisy Weston; Rachael Metheringham; Victoria Brentville; Lindy Durrant
Journal:  Front Immunol       Date:  2022-04-08       Impact factor: 8.786

Review 7.  Citrullination and PAD Enzyme Biology in Type 1 Diabetes - Regulators of Inflammation, Autoimmunity, and Pathology.

Authors:  Mei-Ling Yang; Fernanda M C Sodré; Mark J Mamula; Lut Overbergh
Journal:  Front Immunol       Date:  2021-06-01       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.